Conversely, other contributions have shown that, in human colon carcinoma cells, S1P generated by nuclear SphK2 can inhibit the retinoic acid receptor β, attenuating the tumor suppressor effects of this receptor (Shi et al., 2017). Here, SPHK2 is linked to neoplasm.